Tara Rachakonda, MD
Sleep Medicine · Las Vegas, NVNPI 1508093345
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,577 of the $5,825 with a category attached, or 78.6%. 26 manufacturers reported payments, led by ZOLL Respicardia, Inc. at 26.8% of the total. 2025 is the largest year on record at $2,865, 7.0 times the $410 reported in 2019.
Across 179 payments — averaging $32.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Respicardia, Inc.$2K
- Jazz Pharmaceuticals Inc.$1K
- Avadel CNS Pharmaceuticals, LLC$570
- Harmony Biosciences LLC$453
- Axsome Therapeutics, Inc.$427
- Inspire Medical Systems, Inc.$322
- plus $1K from 20 others
What the payments were for
- Travel & lodging$87815%
- Food & beverage$4,57779%
- Education$3696%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Respicardia, Inc. | 5 | $1,561 |
| Jazz Pharmaceuticals Inc. | 47 | $1,420 |
| Avadel CNS Pharmaceuticals, LLC | 34 | $570 |
| Harmony Biosciences LLC | 22 | $453 |
| Axsome Therapeutics, Inc. | 36 | $427 |
| Inspire Medical Systems, Inc. | 4 | $322 |
| Philips North America LLC | 5 | $205 |
| Teva Pharmaceuticals USA, Inc. | 2 | $162 |
| Lilly USA, LLC | 4 | $152 |
| GSK | 2 | $129 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Amarin Pharma, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Idorsia Pharmaceuticals US Inc | 2 | $27 |
| Itamar Medical Inc | 1 | $24 |
| AstraZeneca | 1 | $22 |
| Baxter Healthcare | 1 | $21 |
| Boston Scientific | 1 | $17 |
| Grifols USA, LLC | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Resmed Corp | 1 | $17 |
| OPKO Pharmaceuticals, LLC | 1 | $15 |
| Sanofi | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Fisher & Paykel Healthcare Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few sleep medicine providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Adderall XrDextroamphetamine/Amphetamine | 11 | $5,530 |
| Modafinil | 12 | $425 |
| Zolpidem Tartrate | 55 | $158 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Las Vegas
- Clifford MolinLas Vegas$4K
- Mohamed ShamiyaLas Vegas$960
- Hala SammanLas Vegas$388
- Robert ReynaLas Vegas$70
- Umar NasirReno$6K
- Brandon FloresReno$5K
- Kimberly YeagerReno$4K
- Francis Paul BattungReno$2K
- Alexander BlatyNorth Las Vegas$2K
- William TorchReno$297
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.